Found: 14
Select item for more details and to access through your institution.
The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II).
- Published in:
- Orphanet Journal of Rare Diseases, 2024, v. 19, n. 1, p. 1, doi. 10.1186/s13023-024-03373-w
- By:
- Publication type:
- Article
Classic infantile Pompe patients approaching adulthood: a cohort study on consequences for the brain.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 9, p. 1414, doi. 10.3390/biom13091414
- By:
- Publication type:
- Article
Home-based enzyme replacement therapy in children and adults with Pompe disease; a prospective study.
- Published in:
- Orphanet Journal of Rare Diseases, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13023-023-02715-4
- By:
- Publication type:
- Article
Antibodies against recombinant human alpha-glucosidase do not seem to affect clinical outcome in childhood onset Pompe disease.
- Published in:
- 2022
- By:
- Publication type:
- Journal Article
Enzyme replacement therapy in late‐onset Pompe's disease: A three‐year follow‐up.
- Published in:
- Annals of Neurology, 2004, v. 55, n. 4, p. 495
- By:
- Publication type:
- Article
Diffusion tensor imaging of the brain in Pompe disease.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 3, p. 1662, doi. 10.1007/s00415-022-11506-z
- By:
- Publication type:
- Article
Analysis of urinary oligosaccharide excretion patterns by UHPLC/HRAM mass spectrometry for screening of lysosomal storage disorders.
- Published in:
- Journal of Inherited Metabolic Disease, 2023, v. 46, n. 2, p. 206, doi. 10.1002/jimd.12597
- By:
- Publication type:
- Article
Is the brain involved in patients with late‐onset Pompe disease?
- Published in:
- Journal of Inherited Metabolic Disease, 2022, v. 45, n. 3, p. 493, doi. 10.1002/jimd.12469
- By:
- Publication type:
- Article
Craniosynostosis affects the majority of mucopolysaccharidosis patients and can contribute to increased intracranial pressure.
- Published in:
- Journal of Inherited Metabolic Disease, 2018, v. 41, n. 6, p. 1247, doi. 10.1007/s10545-018-0212-1
- By:
- Publication type:
- Article
Craniosynostosis affects the majority of mucopolysaccharidosis patients and can contribute to increased intracranial pressure.
- Published in:
- Journal of Inherited Metabolic Disease, 2018, v. 41, n. 6, p. 1247, doi. 10.1007/s10545-018-0212-1
- By:
- Publication type:
- Article
Start, switch and stop (triple‐S) criteria for enzyme replacement therapy of late‐onset Pompe disease: European Pompe Consortium recommendation update 2024.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 9, p. 1, doi. 10.1111/ene.16383
- By:
- Publication type:
- Article
A Delphi Survey Study to Formulate Statements on the Treatability of Inherited Metabolic Disorders to Decide on Eligibility for Newborn Screening.
- Published in:
- International Journal of Neonatal Screening (IJNS), 2023, v. 9, n. 4, p. 56, doi. 10.3390/ijns9040056
- By:
- Publication type:
- Article
Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions.
- Published in:
- BioDrugs, 2023, v. 37, n. 5, p. 685, doi. 10.1007/s40259-023-00609-2
- By:
- Publication type:
- Article